🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a phase 1, first-in-human, single-center, randomized, double-blind...
Status
Completed
Location
Clinical Trial Site
Start Date
2017-11-28
Trial ID
NCT05047458
This is a 2-part, open label, fixed-sequence study to evaluate the potentia...
Status
Completed
Location
Clinical Trial Site
Start Date
2021-06-07
Trial ID
NCT04933682
Treatments Being Tested
This was a 2-part study (Part 1 and Part 2), with each part being an open-l...
Status
Completed
Location
Clinical Study Site
Start Date
2019-12-22
Trial ID
NCT04709081
Treatments Being Tested
This study will evaluate the efficacy and safety of ALXN2050 (120 milligram...
Status
Terminated
Location
Research Site
Start Date
2022-04-27
Trial ID
NCT05218096
This study will evaluate the potential drug interactions between ALXN2050 a...
Status
Completed
Location
Clinical Study Site
Start Date
2022-01-11
Trial ID
NCT05202145
Treatments Being Tested
This study will assess the Bioequivalence between 180 mg and 60 mg ALXN2050...
Status
Completed
Location
Research Site
Start Date
2022-10-13
Trial ID
NCT05578846
Treatments Being Tested
This is an open-label study to assess the absorption, metabolism, excretion...
Status
Completed
Location
Clinical Trial Site
Start Date
2021-04-12
Trial ID
NCT04609670
Treatments Being Tested
This will be an open-label, 3-sequence, 3-period crossover study in healthy...
Status
Completed
Location
Clinical Trial Site
Start Date
2020-06-26
Trial ID
NCT04551586
Treatments Being Tested
This study will investigate the impact of impaired hepatic function (IHF) o...
Status
Terminated
Location
Research Site
Start Date
2022-04-07
Trial ID
NCT05259085
Treatments Being Tested